NDAC meeting date canceled
This article was originally published in The Tan Sheet
Executive Summary
Meeting of FDA's Nonprescription Drugs Advisory Committee that was to be held July 27 jointly with the Drug Abuse Advisory Committee has been canceled. Past joint meetings of the two committees have focused on smoking cessation products ("The Tan Sheet" May 26, p. 11). NDAC is scheduled to proceed with its July 28 and 29 meetings to discuss, respectively, labeling of vaginal antifungal products and healthcare antiseptic testing requirements...